EUVIMEDEUVIMED entdecken
Crossref

Mass Balance of the Indoleamine 2,3-Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-a]isoindole and Species Differences in Glucuronidation

Shuai Wang iD, Shuguang Ma, Eugene Chen, Jing Wang, Hoa Le, Steven Paul Hanlon, Martin Binder, Wendy Lee, S Cyrus Khojasteh, Laurent Salphati

Drug Metabolism and Disposition · 2023

DOI: 10.1124/dmd.123.001289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2023. Verfasst von Shuai Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California (S.W., E.C., J.W., H.L., W.L., S.C.K., L.S.); Pliant Therapeut…. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Isoindoles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleamine-Pyrrole 2,3,-DioxygenaseIsoindolesHumansRatsDogsAnimalsCyanidesSpecies SpecificityImidazolesBiotransformationFecesIndoles

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseIsoindolesCyanidesImidazolesnavoximodIndoles

Autor:innen und Institutionen

  • Drug Metabolism and Pharmacokinetics, Genentech, Inc., South San Francisco, California (S.W., E.C., J.W., H.L., W.L., S.C.K., L.S.); Pliant Therapeutics, South San Francisco, California (S.M.); and Process Chemistry & C…

ORCID-Profile: Shuai Wang

Zitieren

APA

Wang, S., Ma, S., Chen, E., Wang, J., Le, H., Hanlon, S. P., Binder, M., Lee, W., Khojasteh, S. C., & Salphati, L. (2023). Mass Balance of the Indoleamine 2,3-Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-a]isoindole and Species Differences in Glucuronidation. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.123.001289

Vancouver

Wang S, Ma S, Chen E, Wang J, Le H, Hanlon SP, et al. Mass Balance of the Indoleamine 2,3-Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-a]isoindole and Species Differences in Glucuronidation. Drug Metabolism and Disposition. 2023. doi:10.1124/dmd.123.001289

BibTeX
@article{Wang2023,
  author = {Wang, Shuai and Ma, Shuguang and Chen, Eugene and Wang, Jing and Le, Hoa and Hanlon, Steven Paul and Binder, Martin and Lee, Wendy and Khojasteh, S Cyrus and Salphati, Laurent},
  title = {Mass Balance of the Indoleamine 2,3-Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-a]isoindole and Species Differences in Glucuronidation},
  journal = {Drug Metabolism and Disposition},
  year = {2023},
  doi = {10.1124/dmd.123.001289}
}
Kostenlos starten →